Ipamorelin vs CJC-1295: GH Secretagogues Research Comparison
Ipamorelin and CJC-1295 No DAC are not competitors — they work on different receptors and are most powerful when combined. But researchers often compare them when deciding which to prioritise or start with. This breakdown covers exactly how they differ and why the combination is so widely used.
Ipamorelin
GHSR agonist — cleanest GHRP
- ✓Activates ghrelin receptor (GHSR)
- ✓No cortisol or ACTH elevation
- ✓Selective GH pulse — cleanest GHRP studied
- ✓~2 hour half-life
- ✓Mild appetite stimulation from GHSR
CJC-1295 No DAC
GHRH analogue — Mod GRF 1-29
- ✓Activates GHRH receptor at pituitary
- ✓Mimics endogenous GHRH signalling
- ✓Pulsatile GH release, 30–60 min half-life
- ✓Synergistic with Ipamorelin (different receptor)
- ✓Available pre-mixed with Ipamorelin
Side-by-Side Comparison
| Factor | Ipamorelin | CJC-1295 No DAC |
|---|---|---|
| Peptide Class | GHRP (Growth Hormone Releasing Peptide) | GHRH analogue (Mod GRF 1-29) |
| Receptor Target | GHSR (Ghrelin receptor) — pituitary | GHRH-R (GHRH receptor) — pituitary |
| Half-Life | ~2 hours | ~30–60 minutes |
| GH Pulse Pattern | Selective GH pulse — no cortisol or ACTH elevation | Pulsatile GH — mimics natural GHRH-induced secretion |
| Cortisol Effect | None at standard doses | None |
| Appetite Stimulation | Mild — ghrelin receptor activity | None |
| Typical Dose | 100–200 mcg per injection | 100–200 mcg per injection |
| Used Alone | Yes — clean solo GH secretagogue | Yes — moderate GH elevation alone |
| Combined Effect | Synergistic when paired with CJC-1295 | Synergistic when paired with Ipamorelin |
| Pre-Mixed Blend Available | Yes — CJC-1295/Ipamorelin Blend | Yes — CJC-1295/Ipamorelin Blend |
Why Ipamorelin + CJC-1295 Is More Powerful Than Either Alone
The Two-Receptor Model
GH release from pituitary somatotroph cells is controlled by two primary stimulatory inputs: GHRH (via the GHRH-R) and ghrelin (via GHSR). These are separate receptor systems that both converge on stimulating GH secretion from the same cells — but through different intracellular signalling cascades.
CJC-1295 activates the GHRH-R pathway (adenylyl cyclase/cAMP/PKA). Ipamorelin activates the GHSR pathway (phospholipase C/IP3/DAG). When both are present simultaneously, they amplify GH release more than either pathway alone — this is true pharmacological synergy, not just additivity.
The result is that co-administration of CJC-1295 (100–200 mcg) + Ipamorelin (100–200 mcg) in one injection produces a GH pulse magnitude that would require significantly higher doses of either compound to achieve independently.
Why Ipamorelin Is the Preferred GHRP Partner
There are multiple GHRP/GHSR agonists available in research — including GHRP-2 and GHRP-6 — but Ipamorelin is almost universally preferred for long-term GH research for one reason: selectivity.
GHRP-2 and GHRP-6 raise cortisol and ACTH alongside GH. Over time, this cortisol elevation is metabolically counterproductive and confounds research outcomes. Ipamorelin produces the same GHSR activation with minimal cortisol or ACTH response — the GH pulse is clean and isolated.
GHRP-6 also potently stimulates appetite via GHSR (the same mechanism as ghrelin), which Ipamorelin does at significantly lower levels. For body composition research, Ipamorelin's profile is substantially cleaner.
CJC-1295 / Ipamorelin Blend — Pre-Mixed for Convenience
Available pre-combined in a single vial in a 1:1 ratio. One injection instead of two, optimal synergy, lower cost than purchasing separately. The most popular GH axis product in our catalogue.
Frequently Asked Questions
What is the difference between Ipamorelin and CJC-1295?
Ipamorelin is a selective GHRP (growth hormone releasing peptide) that activates the ghrelin receptor (GHSR) at the pituitary. CJC-1295 No DAC (Mod GRF 1-29) is a GHRH analogue that activates the GHRH receptor at the pituitary. They target two completely different receptor systems that both stimulate GH release from somatotroph cells — which is why combining them produces synergistic (not just additive) GH output.
Should I use Ipamorelin alone or combined with CJC-1295?
The CJC-1295 + Ipamorelin combination is the most researched GH peptide protocol and consistently produces greater GH output than either compound alone. Ipamorelin alone produces clean, selective GH pulses without raising cortisol or ACTH — making it the safest standalone GHRP. CJC-1295 alone produces moderate GH elevation. Combined, the two receptor pathways synergise for amplified GH pulses in a single injection.
Does Ipamorelin raise cortisol or ACTH?
No — this is Ipamorelin's defining research characteristic. Unlike older GHRPs such as GHRP-2 and GHRP-6, Ipamorelin does not significantly elevate cortisol or ACTH at effective GH-stimulating doses. This selective GH pulse without HPA axis activation makes Ipamorelin the cleanest GHRP studied and the preferred GHSR agonist for long-term GH research.
What is the CJC-1295 Ipamorelin dosing protocol?
The most researched protocol combines CJC-1295 No DAC (100–200 mcg) with Ipamorelin (100–200 mcg) in a single injection once daily, typically before sleep to align with the natural nocturnal GH pulse. Some protocols use twice-daily injections (morning and pre-sleep). The CJC-1295/Ipamorelin blend is also available as a pre-mixed vial in a 1:1 ratio.
Research use only. All products sold by JA Performance are strictly for laboratory and in vitro research purposes. Not for human consumption, medical use, or veterinary use.